Modulation of coxsackie and adenovirus receptor expression for gene transfer to normal and dystrophic skeletal muscle

Journal of Gene Medicine

Volumn 12, Issue 3, 2010, Pages 266-275

  Larochelle, Nancy ^a   Teng, Qingshan ^a,c   Gilbert, Rénald ^a,d   Deol, Jatinderpal R ^b   Karpati, George ^a,b   Holland, Paul C ^a,b   Nalbantoglu, Josephine ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c LERNER RESEARCH INSTITUTE   (United States)

^d NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Coxsackie and adenovirus receptor; Dystrophin; Skeletal muscle; Transgenic; Valproate

Indexed keywords

BETA GALACTOSIDASE; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; DYSTROPHIN; PARVOVIRUS VECTOR; VALPROIC ACID;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS; FEMALE; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MALE; MOUSE; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE; TIBIALIS ANTERIOR MUSCLE; TISSUE DISTRIBUTION; TRANSGENIC MOUSE;

ADENOVIRIDAE; ANIMALS; DYSTROPHIN; MICE; MICE, INBRED MDX; MICE, TRANSGENIC; MUSCLE FIBERS, SKELETAL; MUSCULAR DYSTROPHIES; RECEPTORS, VIRUS; REGENERATION; TRANSCRIPTION, GENETIC; TRANSDUCTION, GENETIC; VALPROIC ACID;

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE; ANIMALIA; MUS; MUS MUSCULUS;

EID: 77349100183     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1433     Document Type: Article

References (30)

1. Bergelson JM, Cunningham JA, Droguett G, et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320-1323.
2. Tomko RP, Xu R, Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci USA 1997; 94: 3352-3356.
3. Wickham TJ, Mathias P, Cheresh DA, Nemerow GR. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 1993; 73: 309-319.
4. Acsadi G, Jani A, Massie B, et al. A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum Mol Genet 1994; 3: 579-584.
5. Feero WG, Rosenblatt JD, Huard J, et al. Viral gene delivery to skeletal muscle: insights on maturation-dependent loss of fiber infectivity for adenovirus and herpes simplex type 1 viral vectors. Hum Gene Ther 1997; 8: 371-380.
6. Kass-Eisler A, Falck-Pedersen E, Elfenbein DH, Alvira M, Buttrick PM, Leinwand LA. The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther 1994; 1: 395-402.
7. Nalbantoglu J, Pari G, Karpati G, Holland PC. Expression of the primary coxsackie and adenovirus receptor is downregulated during skeletal muscle maturation and limits the efficacy of adenovirus-mediated gene delivery to muscle cells. Hum Gene Ther 1999; 10: 1009-1019.
8. Shaw CA, Holland PC, Sinnreich M, et al. Isoform-specific expression of the Coxsackie and adenovirus receptor (CAR) in neuromuscular junction and cardiac intercalated discs. BMC Cell Biol 2004; 5: 42.
9. Acsadi G, Lochmuller H, Jani A, et al. Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer. Hum Gene Ther 1996; 7: 129-140.
10. Cho WK, Ebihara S, Nalbantoglu J, et al. Modulation of Starling forces and muscle fiber maturity permits adenovirus-mediated gene transfer to adult dystrophic (mdx) mice by the intravascular route. Hum Gene Ther 2000; 11: 701-714.
11. Nalbantoglu J, Larochelle N, Wolf E, Karpati G, Lochmuller H, Holland PC. Muscle-specific overexpression of the adenovirus primary receptor CAR overcomes low efficiency of gene transfer to mature skeletal muscle. J Virol 2001; 75: 4276-4282.
12. Xiao X, Li J, Samulski RJ. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol 1998; 72: 2224-2232.
13. Zolotukhin S, Byrne BJ, Mason E, et al. Recombinant adenoassociated virus purification using novel methods improves infectious titer and yield. Gene Ther 1999; 6: 973-985.
14. Gilbert R, Dudley RW, Liu AB, Petrof BJ, Nalbantoglu J, Karpati G. Prolonged dystrophin expression and functional correction of mdx mouse muscle following gene transfer with a helper-dependent (gutted) adenovirus-encoding murine dystrophin. Hum Mol Genet 2003; 12: 1287-1299.
15. Alexander IE, Russell DW, Miller AD. DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors. J Virol 1994; 68: 8282-8287.
16. Larochelle N, Deol JR, Srivastava V, et al. Downregulation of CD46 during muscle differentiation: implications for gene transfer to human skeletal muscle using group B adenoviruses. Hum Gene Ther 2008; 19: 133-142.
17. Shaw CA, Larochelle N, Dudley RW, et al. Simultaneous dystrophin and dysferlin deficiencies associated with high-level expression of the coxsackie and adenovirus receptor in transgenic mice. Am J Pathol 2006; 169: 2148-2160.
18. Bergelson JM, Krithivas A, Celi L, et al. The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses. J Virol 1998; 72: 415-419.
19. Parks RJ, Chen L, Anton M, Sankar U, Rudnicki MA, Graham FL. A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc Natl Acad Sci USA 1996; 93: 13565-13570.
20. Kitazono M, Rao VK, Robey R, et al. Histone deacetylase inhibitor FR901228 enhances adenovirus infection of hematopoietic cells. Blood 2002; 99: 2248-2251.
21. Gurvich N, Berman MG, Wittner BS, Gentleman RC, Klein PS, Green JB. Association of valproate-induced teratogenesis with histone deacetylase inhibition in vivo. FASEB J 2005; 19: 1166-1168.
22. Passos-Bueno MR, Vainzof M, Marie SK, Zatz M. Half the dystrophin gene is apparently enough for a mild clinical course: confirmation of its potential use for gene therapy. Hum Mol Genet 1994; 3: 919-922.
23. BeggsAH, HoffmanEP, SnyderJR, et al. Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. Am J Hum Genet 1991; 49: 54-67.
24. Sinnreich M, Shaw CA, Pari G, Nalbantoglu J, Holland PC, Karpati G. Localization of coxsackie virus and adenovirus receptor (CAR) in normal and regenerating human muscle. Neuromuscul Disord 2005; 15: 541-548.
25. Anderson JE, Ovalle WK, Bressler BH. Electron microscopic and autoradiographic characterization of hindlimb muscle regeneration in the mdx mouse. Anat Rec 1987; 219: 243-257.
26. Uchino M, Araki S, Miike T. Correlative study of the incidence of opaque, necrotic and regenerative fibers in Duchenne dystrophy. Acta Neuropathol (Berl) 1988; 75: 308-312.
27. Morizumi H, Hizawa K, Nunomura S, Ii K. Comparative study of alterations of skeletal muscle in Duchenne muscular dystrophy and polymyositis. Acta Pathol Jpn 1984; 34: 1221-1242.
28. Glasgow JN, Everts M, Curiel DT. Transductional targeting of adenovirus vectors for gene therapy. Cancer Gene Ther 2006; 13: 830-844.
29. Gregorevic P, Blankinship MJ, Allen JM, et al. Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat Med 2004; 10: 828-834.
30. Yue Y, Ghosh A, Long C, et al. A single intravenous injection of adeno-associated virus serotype-9 leads to whole body skeletal muscle transduction in dogs. Mol Ther 2008; 16: 1944-1952.